Striatal Dopamine Receptor Binding in People at Clinical and Genetic High Risk for Psychosis

被引：0
|
作者：
van Amelsvoort, Therese [1 ]
Boot, Erik [2 ]
Bloemen, Oswald [2 ]
de Koning, Mariken [2 ]
Booij, Jan [3 ]
机构：
[1] Maastricht Univ, Dept Psychiat & Psychol, Maastricht, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1105 AZ Amsterdam, Netherlands
来源：
BIOLOGICAL PSYCHIATRY | 2013年 / 73卷 / 09期
关键词：
DOPAMINE; PSYCHOSIS; 22Q11DS; UHR; SPECT;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
925
引用
收藏
页码：295S / 296S
页数：2
相关论文
共 50 条
  • [1] Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis
    Bloemen, Oswald J. N.
    de Koning, Mariken B.
    Gleich, Tobias
    Meijer, Julia
    de Haan, Lieuwe
    Linszen, Don H.
    Booij, Jan
    van Amelsvoort, Therese A. M. J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (02) : 126 - 132
  • [2] ABNORMAL PREFRONTAL ACTIVATION RELATED TO STRIATAL DOPAMINE DYSFUNCTION IN PEOPLE AT CLINICAL RISK FOR PSYCHOSIS
    Fusar-Poli, Paolo
    [J]. SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 169 - 169
  • [3] Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes
    Gemma Modinos
    Anja Richter
    Alice Egerton
    Ilaria Bonoldi
    Matilda Azis
    Mathilde Antoniades
    Matthijs Bossong
    Nicolas Crossley
    Jesus Perez
    James M. Stone
    Mattia Veronese
    Fernando Zelaya
    Anthony A. Grace
    Oliver D. Howes
    Paul Allen
    Philip McGuire
    [J]. Neuropsychopharmacology, 2021, 46 : 1468 - 1474
  • [4] Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes
    Modinos, Gemma
    Richter, Anja
    Egerton, Alice
    Bonoldi, Ilaria
    Azis, Matilda
    Antoniades, Mathilde
    Bossong, Matthijs
    Crossley, Nicolas
    Perez, Jesus
    Stone, James M.
    Veronese, Mattia
    Zelaya, Fernando
    Grace, Anthony A.
    Howes, Oliver D.
    Allen, Paul
    McGuire, Philip
    [J]. NEUROPSYCHOPHARMACOLOGY, 2021, 46 (08) : 1468 - 1474
  • [5] Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis
    Fusar-Poli, P.
    Howes, O. D.
    Allen, P.
    Broome, M.
    Valli, I.
    Asselin, M-C
    Montgomery, A. J.
    Grasby, P. M.
    McGuire, P.
    [J]. MOLECULAR PSYCHIATRY, 2011, 16 (01) : 67 - 75
  • [6] Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis
    P Fusar-Poli
    O D Howes
    P Allen
    M Broome
    I Valli
    M-C Asselin
    A J Montgomery
    P M Grasby
    P McGuire
    [J]. Molecular Psychiatry, 2011, 16 : 67 - 75
  • [7] Striatal D2 receptor binding in subjects at ultra high risk for psychosis
    Bloemen, O.
    Koning, M. D.
    Booij, J.
    Linszen, D.
    Amelsvoort, T. V.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 214 - 214
  • [8] Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
    Egerton, Alice
    Chaddock, Christopher A.
    Winton-Brown, Toby T.
    Bloomfield, Michael A. P.
    Bhattacharyya, Sagnik
    Allen, Paul
    McGuire, Philip K.
    Howes, Oliver D.
    [J]. BIOLOGICAL PSYCHIATRY, 2013, 74 (02) : 106 - 112
  • [9] Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis A Randomized Clinical Trial
    Bhattacharyya, Sagnik
    Wilson, Robin
    Appiah-Kusi, Elizabeth
    O'Neill, Aisling
    Brammer, Michael
    Perez, Jesus
    Murray, Robin
    Allen, Paul
    Bossong, Matthijs G.
    McGuire, Philip
    [J]. JAMA PSYCHIATRY, 2018, 75 (11) : 1107 - 1117
  • [10] Dysregulation of Striatal Dopamine Receptor Binding in Suicide
    Fitzgerald, Megan L.
    Kassir, Suham A.
    Underwood, Mark D.
    Bakalian, Mihran J.
    Mann, J. John
    Arango, Victoria
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 (04) : 974 - 982
12345